Title: Atorvastatin Efficacy of Treatment of Alzheimer's Disease
Abstract:Objective:To investigate the effects ofstatins in improving cognitive dysfunction in Alzheimer's disease role.Methods:The Alzheimer's disease in 40 patients,randomly divided into treatment groups(ator...Objective:To investigate the effects ofstatins in improving cognitive dysfunction in Alzheimer's disease role.Methods:The Alzheimer's disease in 40 patients,randomly divided into treatment groups(atorvastatin 20mg 1 time/day orally) and control group(aniracetam 0.2g 3 times/day orally),continuous medication 90d,in the 30d,60d,90d,respectively,cognitive function score of two groups of patients(Mini-Mental Scale).Results:Calculated using the t-test t-value,30d comparison,t=0.938(P0.05,the difference was not statistically significant);60d comparison,t=1.333(P0.05,the difference was not statistically significant);90d compare t=2.356(P0.05,statistically significant difference),suggesting that 90 days after the treatment group improved cognitive function than the control group,and with the treatment time,the advantage can be more obvious.Conclusion:Atorvastatin maycontribute to the treatment of Alzheimer's disease.Read More
Publication Year: 2012
Publication Date: 2012-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot